Skip to main content
NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
FG

Fulgent Genetics, Inc. (FLGT)

NASDAQ • Healthcare

$19.85
-$0.34 (-1.7%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$20.09
Previous Close$19.85
Day Range$19.61 - $20.09
Avg. Volume (3M)253.1K
Market Cap$563.7M
52 Week Range
$13.46$31.04
Next EarningsIn 57 daysNov 6, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$85.3M100%
Gross Profitminus cost of goods$25.6M30%

In plain terms: out of every $100 in revenue, Fulgent Genetics, Inc. currently loses $35.

Fundamentals & Financials

Revenue (TTM)
$323.9M
Net Income (TTM)
-$84.3M
EPS (TTM)
-$2.82
ROA (TTM)
-7.75%
Current Ratio
6.34
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+433.3%Q1 2026$0.16
-3.4%Q2 2026-$0.36
-26.1%Q3 2026-$0.58
Next

Nov 6

in 57 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -26.1%

Fulgent Genetics’ revenue in the second fiscal quarter of 2026 trailed consensus, with results reported July 30, 2026 showing revenue rose 4.4% to about $85.4 million, but still came in at $85.4 million versus a $94.0 million estimate (-9.2%, trailed). The top line reflected continued demand across its laboratory testing and genomic analysis offering, including molecular diagnostic and broader genetic testing services. Profitability remained pressured, with gross profit of roughly $25.7 million translating to a gross margin of about 30%, while operating loss was around $33.9 million and operating margin was near -40%. Net income was a loss of roughly $29.5 million, down 55.8% from a loss of about $19.0 million a year ago. Cash flow also ran negative, with negative operating cash flow of about $23.8 million, alongside $23.8 million of share repurchases during the quarter. For the next period, consensus calls for EPS of -$0.65 on revenue of $86.3 million.

View full earnings history

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. provides laboratory testing and genomic analysis in healthcare and trades on the NASDAQ under FLGT. The company delivers COVID-19 testing services, molecular diagnostic testing services, and broader genetic testing, with $322.7 million of revenue in FY2025. It serves customers globally across clinical, institutional, governmental, corporate, and direct-to-patient channels.

Name
Fulgent Genetics, Inc.
CEO
Ming Hsieh
Website
www.fulgentgenetics.com
Industry
Healthcare
Year Founded
2011
Employees
1,315

Today's Snapshot

AI-generated

The session opened with FLGT 0.8% lower at 19.69, in line with a flat sector.

Trading Volume

Below 10d avg (280.2K)

38K

vs S&P 500 Today

Outperforming Market

+0.70%

Updated: September 10, 2026 at 14:43 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
FLGT trades near 19.62 with an overall buy bias driven by mixed but slightly constructive internals. Trend strength is muted with ADX in the mid-teens, while momentum is largely neutral—RSI around 51 and MACD slightly positive—reflecting a balanced market. Price sits around short- and medium-term averages and below the 200-day, which introduces longer-term resistance even as the 100-day series offers support. Volatility is moderate and on-balance volume is positive, and the pivot is slightly above the market. Technical takeaway: buy — constructive medium-term structure amid near-term consolidation.
All signals
  • EMA (5 indicators)$19.22 - $20.82
    Buy
  • RSI (14)50.86
    Neutral
  • Stochastic %K (14, 3, 3)59.61
    Neutral
  • MACD Level (12, 26)0.16
    Buy

Peers & Related Assets

CDNACareDx, Inc
$50.03-0.6%
BFLYButterfly Network, Inc.
$7.46-0.8%
CSTLCastle Biosciences, Inc.
$32.31-1.4%
ARVNArvinas, Inc.
$8.76-3.5%
PACBPacific Biosciences of California, Inc.
$1.29-2.3%
MYGNMyriad Genetics, Inc.
$3.19+0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.